MeSH D017119 - porphyria cutanea tarda
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Hydroxychloroquine | Hydroxychloroquine | 2020-04-07 | |||
| Allergan | Hydroxychloroquine | Hydroxychloroquine | 1995-11-30 | |||
| Amneal Pharmaceuticals | Hydroxychloroquine | Hydroxychloroquine | 2018-05-15 | |||
| ANDA Repository | Hydroxychloroquine | Hydroxychloroquine | 2020-05-14 | |||
| Appco Pharma | Hydroxychloroquine | Hydroxychloroquine | 2018-05-01 | |||
| Aurobindo Pharma | Hydroxychloroquine | Hydroxychloroquine | 1998-05-29 | |||
| Chartwell Pharmaceuticals | Hydroxychloroquine | Hydroxychloroquine | 2018-07-06 | |||
| Hikma Pharmaceuticals | Hydroxychloroquine | Hydroxychloroquine | 2007-08-15 | |||
| Invatech Pharma Solutions | Hydroxychloroquine | Hydroxychloroquine | 1996-01-27 | |||
| Laurus Labs | Hydroxychloroquine | Hydroxychloroquine | 2019-01-15 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
25%1/4
Phase 3
50%1/2
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use